Veru, Inc. (VERU)
2.625
-0.12
(-4.20%)
USD |
NASDAQ |
Aug 28, 16:00
2.64
+0.02
(+0.57%)
After-Hours: 20:00
Veru Total Return Price : 2.625 for Aug. 28, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| August 28, 2026 | 2.625 |
| August 27, 2026 | 2.74 |
| August 26, 2026 | 2.80 |
| August 25, 2026 | 2.71 |
| August 24, 2026 | 2.59 |
| August 21, 2026 | 2.64 |
| August 20, 2026 | 2.58 |
| August 19, 2026 | 2.64 |
| August 18, 2026 | 2.59 |
| August 17, 2026 | 2.63 |
| August 14, 2026 | 2.73 |
| August 13, 2026 | 2.70 |
| August 12, 2026 | 2.74 |
| August 11, 2026 | 2.79 |
| August 10, 2026 | 2.77 |
| August 07, 2026 | 2.33 |
| August 06, 2026 | 2.31 |
| August 05, 2026 | 2.33 |
| August 04, 2026 | 2.37 |
| August 03, 2026 | 2.26 |
| July 31, 2026 | 2.24 |
| July 30, 2026 | 2.22 |
| July 29, 2026 | 2.21 |
| July 28, 2026 | 2.23 |
| July 27, 2026 | 2.28 |
| Date | Value |
|---|---|
| July 24, 2026 | 2.25 |
| July 23, 2026 | 2.31 |
| July 22, 2026 | 2.26 |
| July 21, 2026 | 2.34 |
| July 20, 2026 | 2.30 |
| July 17, 2026 | 2.38 |
| July 16, 2026 | 2.35 |
| July 15, 2026 | 2.42 |
| July 14, 2026 | 2.31 |
| July 13, 2026 | 2.56 |
| July 10, 2026 | 2.78 |
| July 09, 2026 | 2.81 |
| July 08, 2026 | 2.66 |
| July 07, 2026 | 2.88 |
| July 06, 2026 | 2.83 |
| July 02, 2026 | 3.06 |
| July 01, 2026 | 3.16 |
| June 30, 2026 | 3.13 |
| June 29, 2026 | 3.12 |
| June 26, 2026 | 3.01 |
| June 25, 2026 | 2.94 |
| June 24, 2026 | 2.97 |
| June 23, 2026 | 3.04 |
| June 22, 2026 | 2.96 |
| June 18, 2026 | 2.95 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| ANI Pharmaceuticals, Inc. | 72.83 |
| Corcept Therapeutics, Inc. | 113.88 |
| Johnson & Johnson | 268.04 |
| Eli Lilly & Co. | 1174.61 |
| Lexicon Pharmaceuticals, Inc. | 2.29 |